Tamanna Prashar - 09 Jun 2021 Form 4 Insider Report for Lucira Health, Inc.

Role
Vice President
Signature
/s/ Dan George, Attorney-in-Fact for Tamanna Prashar
Issuer symbol
N/A
Transactions as of
09 Jun 2021
Net transactions value
+$99,108
Form type
4
Filing time
14 Feb 2022, 16:52:41 UTC
Next filing
12 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Options Exercise $65,177 +79,484 +693% $0.8200* 90,959 09 Jun 2021 Direct
transaction LHDXQ Common Stock Options Exercise $1,834 +2,513 +2.8% $0.7300* 93,472 09 Jun 2021 Direct
transaction LHDXQ Common Stock Options Exercise $7,762 +10,633 +11% $0.7300* 104,105 09 Jun 2021 Direct
transaction LHDXQ Common Stock Options Exercise $24,334 +11,061 +11% $2.20* 115,166 09 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LHDXQ Stock Option (right to buy) Options Exercise $0 -79,484 -48% $0.000000 86,397 09 Jun 2021 Common Stock 79,484 $0.8200 Direct F1
transaction LHDXQ Stock Option (right to buy) Options Exercise $0 -2,513 -27% $0.000000 6,767 09 Jun 2021 Common Stock 2,513 $0.7300 Direct F2
transaction LHDXQ Stock Option (right to buy) Options Exercise $0 -10,633 -23% $0.000000 35,767 09 Jun 2021 Common Stock 10,633 $0.7300 Direct F2
transaction LHDXQ Stock Option (right to buy) Options Exercise $0 -11,061 -6.6% $0.000000 156,604 09 Jun 2021 Common Stock 11,061 $2.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option are immediately exercisable. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
F2 The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date.